Filing Details
- Accession Number:
- 0001140361-24-045099
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-04 16:05:26
- Reporting Period:
- 2024-10-31
- Accepted Time:
- 2024-11-04 16:05:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1281895 | Rocket Pharmaceuticals Inc. | RCKT | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1662170 | John Militello | C/O Rocket Pharmaceuticals, Inc. 9 Cedarbrook Drive Cranbury NJ 08512 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-10-31 | 917 | $16.63 | 50,534 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis.
- The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.